Capital Research Global Investors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.14B Buy
8,739,988
+5,870,178
+205% +$1.37B 0.33% 70
2025
Q4
$594M Sell
2,869,810
-144,917
-5% -$28.7M 0.11% 137
2025
Q3
$559M Sell
3,014,727
-372,720
-11% -$63.9M 0.1% 136
2025
Q2
$517M Buy
3,387,447
+930,030
+38% +$143M 0.1% 140
2025
Q1
$408M Buy
2,457,417
+3,597
+0.1% +$563K 0.09% 151
2024
Q4
$355M Buy
2,453,820
+1,311,736
+115% +$203M 0.07% 164
2024
Q3
$185M Buy
1,142,084
+946
+0.1% +$151K 0.04% 228
2024
Q2
$167M Buy
1,141,138
+505,000
+79% +$75.1M 0.04% 237
2024
Q1
$101M Buy
636,138
+323
+0.1% +$51.4K 0.02% 287
2023
Q4
$99.7M Sell
635,815
-31
-0% -$4.75K 0.02% 281
2023
Q3
$99M Sell
635,846
-191,936
-23% -$31.7M 0.03% 276
2023
Q2
$137M Buy
827,782
+366
+0% +$59.1K 0.04% 259
2023
Q1
$128M Sell
827,416
-843,135
-50% -$136M 0.04% 261
2022
Q4
$295M Hold
1,670,551
0.09% 177
2022
Q3
$273M Buy
1,670,551
+843,394
+102% +$143M 0.09% 178
2022
Q2
$147M Sell
827,157
-222
-0% -$39.6K 0.05% 245
2022
Q1
$147M Buy
827,379
+19
+0% +$3.23K 0.04% 270
2021
Q4
$142M Sell
827,360
-194
-0% -$31.8K 0.03% 284
2021
Q3
$134M Buy
827,554
+174
+0% +$29.7K 0.03% 287
2021
Q2
$136M Sell
827,380
-603,571
-42% -$99.9M 0.03% 273
2021
Q1
$235M Sell
1,430,951
-6
-0% -$971 0.06% 229
2020
Q4
$225M Sell
1,430,957
-725,177
-34% -$107M 0.06% 230
2020
Q3
$321M Sell
2,156,134
-417
-0% -$61.7K 0.1% 172
2020
Q2
$303M Sell
2,156,551
-50,725
-2% -$7.39M 0.1% 164
2020
Q1
$289M Sell
2,207,276
-691,374
-24% -$98.1M 0.11% 149
2019
Q4
$423M Buy
2,898,650
+1,566
+0.1% +$212K 0.13% 156
2019
Q3
$375M Sell
2,897,084
-1,050,414
-27% -$138M 0.12% 160
2019
Q2
$550M Sell
3,947,498
-2,181,998
-36% -$302M 0.17% 126
2019
Q1
$857M Sell
6,129,496
-113
-0% -$15.1K 0.27% 81
2018
Q4
$791M Buy
6,129,609
+622,705
+11% +$86.9M 0.28% 78
2018
Q3
$761M Sell
5,506,904
-1,270,099
-19% -$169M 0.22% 97
2018
Q2
$822M Sell
6,777,003
-747,594
-10% -$93.3M 0.22% 105
2018
Q1
$964M Buy
7,524,597
+580,853
+8% +$78.5M 0.27% 93
2017
Q4
$970M Buy
6,943,744
+305,029
+5% +$42.5M 0.28% 90
2017
Q3
$863M Sell
6,638,715
-961
-0% -$127K 0.26% 100
2017
Q2
$878M Buy
6,639,676
+1,099
+0% +$140K 0.27% 97
2017
Q1
$827M Sell
6,638,577
-602,008
-8% -$71.9M 0.26% 103
2016
Q4
$834M Sell
7,240,585
-497,106
-6% -$57.4M 0.27% 97
2016
Q3
$914M Sell
7,737,691
-224
-0% -$27.2K 0.3% 84
2016
Q2
$939M Sell
7,737,915
-497,085
-6% -$56.5M 0.32% 82
2016
Q1
$891M Hold
8,235,000
0.31% 87
2015
Q4
$846M Hold
8,235,000
0.29% 93
2015
Q3
$769M Buy
8,235,000
+2,800,000
+52% +$271M 0.27% 92
2015
Q2
$530M Buy
5,435,000
+1,090,000
+25% +$109M 0.17% 134
2015
Q1
$437M Sell
4,345,000
-2,000,000
-32% -$203M 0.15% 144
2014
Q4
$663M Hold
6,345,000
0.23% 112
2014
Q3
$676M Hold
6,345,000
0.23% 108
2014
Q2
$664M Hold
6,345,000
0.23% 118
2014
Q1
$623M Hold
6,345,000
0.23% 119
2013
Q4
$581M Hold
6,345,000
0.22% 122
2013
Q3
$550M Hold
6,345,000
0.22% 117
2013
Q2
$545M Buy
+6,345,000
New +$538M 0.23% 115

Other funds holding JNJ

Capital Research Global Investors's JNJ Position: Q1 2026 in Review

Capital Research Global Investors increased its Johnson & Johnson (JNJ) stake by 205% in Q1 2026, buying an estimated $1.37B and bringing the position to 8,739,988 shares worth $2.14B. The position accounts for 0.33% of the portfolio, ranked #70.

Capital Research Global Investors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,622 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Capital Research Global Investors held 8,739,988 shares of Johnson & Johnson worth $2.14B as of Q1 2026.
  • Capital Research Global Investors bought 5,870,178 Johnson & Johnson shares in Q1 2026, an estimated $1.37B.
  • Johnson & Johnson made up 0.33% of Capital Research Global Investors's portfolio in Q1 2026, its #70 holding.
  • Capital Research Global Investors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,622 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.